SAN FRANCISCO - UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition. Pancreatic cancer is less common than these other cancers, but the lack of treatment options makes it more deadly, and it claims more than 50,000 lives
SAULT STE. MARIE–Lake Superior State University www.announced the launch of a new university-wide initiative designed to provide increased teletherapy and crisis support. In collaboration with the Natick, Mass.-based student mental health and wellness service provider Uwill, the university will increase its existing counseling capabilities with the addition of teletherapy that matches students with a licensed
OXFORD, UK - Scientists from the University of Oxford, the Francis Crick Institute and University College London have used technology similar to the Oxford-AstraZeneca COVID-19 vaccine to create the "LungVax," a vaccine which activates the immune system to kill cancer cells and stop lung cancer. The team has been granted up to $2 million in
SAN DIEGO, CA — Pfizer has announced it will soon expand its footprint into a 230,000 square-foot life science campus in San Diego to conduct cancer research. Pfizer Oncology announced last week it has signed a 15-year lease with Breakthrough Properties, a leading global life sciences real estate developer to move into a 10-acre Torrey
CLEVELAND, Ohio - A new study provides more evidence that sildenafil (Viagra) which is used to treat erectile dysfunction (ED) may help protect against Alzheimer's disease (AD). The large real-world analysis of patient data from two databases showed a 30%-54% reduced prevalence in AD among patients who took sildenafil (Viagra) than those who did not, after adjusting for potential
BOSTON - Brain scans of a 72-year-old man diagnosed with a highly aggressive form of cancer known as a glioblastoma have revealed a remarkable regression in his tumor's size within days of receiving an infusion of an innovative new treatment. Though the outcomes of two other participants with similar diagnoses were somewhat less positive, the case's success still
NEW YORK. - Our immune system is talented at telling the difference between the chemistry of our own body and that of an invading pathogen. When it malfunctions, our body can become host to an intense civil war. Scientists are keen to understand this in more detail, and a newly identified 'switch' that deactivates a
Millions of people living with type 1 diabetes around the world don't have reliable access to insulin. Due to their bodies' inability to produce the hormone, they have to inject it to ensure that glucose can enter cells to produce energy. But finding an affordable and reliable source of insulin has remained difficult in many
NEW YORK - A study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer. This work is published in JAMA Oncology. This
BOULDER, Co. - Scientists have identified a key protein in the development of Alzheimer's disease which could prove critical in slowing or even halting the condition's progress. In tests on mice, a research team led by University of Colorado pharmacologist Tyler Martinez found that blocking a protein called murine double-minute 2 (Mdm2) stopped the destruction
